These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9292911)
1. Implications of early inflammation and infection in cystic fibrosis: a review of new and potential interventions. Weller PH Pediatr Pulmonol; 1997 Aug; 24(2):143-5; discussion 159-61. PubMed ID: 9292911 [TBL] [Abstract][Full Text] [Related]
3. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Mall MA Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954 [TBL] [Abstract][Full Text] [Related]
4. Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis. Konstan MW; Ratjen F J Cyst Fibros; 2012 Mar; 11(2):78-83. PubMed ID: 22093951 [TBL] [Abstract][Full Text] [Related]
9. Therapies aimed at airway inflammation in cystic fibrosis. Konstan MW Clin Chest Med; 1998 Sep; 19(3):505-13, vi. PubMed ID: 9759552 [TBL] [Abstract][Full Text] [Related]
10. Hypertonic saline for cystic fibrosis: worth its salt? Goralski JL; Donaldson SH Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113 [TBL] [Abstract][Full Text] [Related]
11. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037 [TBL] [Abstract][Full Text] [Related]
12. Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway. Balázs A; Mall MA Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S5-S12. PubMed ID: 31715090 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and adverse effects of drugs used to treat adult cystic fibrosis. Chopra R; Paul L; Manickam R; Aronow WS; Maguire GP Expert Opin Drug Saf; 2015 Mar; 14(3):401-11. PubMed ID: 25604518 [TBL] [Abstract][Full Text] [Related]
14. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Geller DE; Eigen H; Fiel SB; Clark A; Lamarre AP; Johnson CA; Konstan MW Pediatr Pulmonol; 1998 Feb; 25(2):83-7. PubMed ID: 9516090 [TBL] [Abstract][Full Text] [Related]
15. Dornase alfa for cystic fibrosis. Jones AP; Wallis C Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314 [TBL] [Abstract][Full Text] [Related]
16. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis. Hodson ME Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698 [TBL] [Abstract][Full Text] [Related]
17. Aerosolized dornase alfa in cystic fibrosis: is there a role in the management of patients with early obstructive lung disease? Geller DE Pediatr Pulmonol; 1997 Aug; 24(2):155-8; discussion 159-61. PubMed ID: 9292913 [TBL] [Abstract][Full Text] [Related]
18. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]